Abstract

Fenugreek is known since ancient times as a traditional herbal medicine of its multiple beneficial effects. Fenugreek's most studied and employed effect is its hypoglycemic property, but it can also be useful for the treatment of certain thyroid disorders or for the treatment of anorexia. The regulation of glucose homeostasis is a complex mechanism, dependent on the interaction of different types of hormones and neurotransmitters or other compounds. For the study of how diosgenin and fenugreek seeds modify insulin sensitivity, we used a rat insulin resistance model induced by high-fat diet. Diosgenin in three different doses (1mg/bwkg, 10mg/bwkg, and 50 mg/bwkg, respectively) and fenugreek seed (0.2 g/bwkg) were administered orally for 6 weeks. Insulin sensitivity was determined by hyperinsulinemic euglycemic glucose clamp method. Our research group found that although glucose infusion rate was not significantly modified in either group, the increased insulin sensitivity index and high metabolic clearance rate of insulin found in the 1 mg/kg diosgenin and the fenugreek seed treated group suggested an improved peripheral insulin sensitivity. Results from the 10 mg/kg diosgenin group, however, suggest a marked insulin resistance. Fenugreek seed therapy results on the investigated anabolic hormones support the theory that, besides insulin and gastrointestinal peptides, the hypothalamic-hypopituitary axis regulated hormones synchronized action with IGF-1 also play an important role in the maintaining of normal glucose levels. Both diosgenin and fenugreek seeds are capable of interacting with substrates of the above-mentioned regulatory mechanisms, inducing serious hormonal disorders. Moreover, fenugreek seeds showed the ability to reduce the thyroid hormone levels at the periphery and to modify the T4/T3 ratio. It means that in healthy people this effect could be considered a severe side effect; however, in hypothyroidism this effect represents a possibility of alternative natural therapy.

Highlights

  • Fenugreek (Trigonella foenum-graecum) appears to be rich in phytonutrients with multiple pharmacological effects [1,2,3,4]

  • Our research group found that glucose infusion rate was not significantly modified in either group, the increased insulin sensitivity index and high metabolic clearance rate of insulin found in the 1 mg/kg diosgenin and the fenugreek seed treated group suggested an improved peripheral insulin sensitivity

  • Since in Hyperinsulinemic Euglycemic Glucose Clamp (HEGC) blood glucose is artificially kept in the euglycemic state, there was no significant difference between groups

Read more

Summary

Introduction

Fenugreek (Trigonella foenum-graecum) appears to be rich in phytonutrients with multiple pharmacological effects [1,2,3,4]. A fenugreek seed and/or seed extracts were found to increase glucose uptake; reduced glycosylated haemoglobin levels together with proinflammatory cytokines and pancreatic enzymes; in dose-dependent manner restored the glycogen levels in muscle and liver; inhibited lipid peroxidation; and reinstated some antioxidant enzymes-glutathione (GSH) and superoxide dismutase (SOD) activities in the liver and pancreas [25]. Diabetic rats treated with fenugreek showed reduced serum glucose levels, and the activities of antioxidant defence enzymes increased due to the expression of the mentioned genes in the liver or/and brain [27]. Vıgh et al were able to correlate the chemical composition of fenugreek seed extracts with reduced viability of the T-47D and ZR-75-1 breast cancer cell lines [34]. Our results further demonstrate the importance of careful dose-dependent assessment of fenugreek specific pharmacological effects

Analytical Examination of Fenugreek Seeds
Animals and Protocols
Sample Preparation and Determination of Hormone Levels
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call